Pain Management

A peer-delivered, cognitive behavioral therapy-based intervention improved functioning, pain, quality of life and self-reported physical activity in patients with diabetes and chronic pain, researchers reported in Annals of Family Medicine.

Cannabinoids did not appear to reduce cancer-associated pain among adults with cancer, according to results of a systemic review and meta-analysis published in BMJ Supportive & Palliative Care.

DALLAS — Patients who underwent preoperative mindfulness training prior to total joint arthroplasty as part of a three-arm randomized trial involving different behavioral pain management techniques showed a clinically and statistically significant improvement in patient-reported function outcome scores at 6 weeks postoperatively, according to a speaker at the American Association of Hip and Knee Surgeons Annual Meeting.

A novel predictive model appeared to identify cancer survivors at increased risk for opioid misuse, according to study results published in Journal of the National Cancer Institute.

ORLANDO — Oral supplementation with arginine resulted in faster resolution of pain associated with vaso-occlusive episodes among younger patients with sickle cell disease, according to the results of a randomized phase 2 trial presented at ASH Annual Meeting and Exposition.

An updated version of an established model for major depressive disorder offers a “useful foundation” toward a comprehensive developmental model of prescription opioid use disorder, according to study results published in Journal of Clinical Psychiatry.

As someone who has been in orthopaedic surgery for nearly 4 decades, I certainly welcome both evolution and innovation. However, I also prefer stability in my orthopaedic practice and tend to be patient when it comes to new advances in the specialty. As a hip surgeon, I have reflected on the implants, surgical techniques, pain management and rehabilitation programs used and the attitudes of the surgeons and patients in 1982, when I began my practice.

In the past few years, physicians and staff at Rothman Orthopaedic Institute have begun to implement a series of preoperative, intraoperative and postoperative protocols to decrease the opioid prescribing, consumption and refill rates.

The Opioid-Prescribing in Dermatology Workgroup determined that 10% of patients or less undergoing 87 common dermatological procedures require postoperative opioid management at discharge.

In 2018, WHO reported musculoskeletal conditions accounted for a greater proportion of persistent pain, with more than 150 diagnoses that affect the locomotor system. Although there are approved medications to treat musculoskeletal pain, sources who spoke with Orthopedics Today said these medications may not work or be suitable for all patients, especially for long term use, depending on their medical status.